Dual local drug delivery of vancomycin and farnesol for mitigation of MRSA infection in vivo - a pilot study. | Eur Cell Mater;40: 38-57, 2020 07 16. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Dual local drug delivery of vancomycin and farnesol for mitigation of MRSA infection in vivo - a pilot study.

Woelfle, U C; Briggs, T; Bhattacharyya, S; Qu, H; Sheth, N; Knabe, C; Ducheyne, P.

Affiliation

Knabe C; Department of Experimental Orofacial Medicine, Philipps University, Marburg, Germany.knabec@med.uni-marburg.de.

Eur Cell Mater ; 40: 38-57, 2020 07 16.

Article in En | MEDLINE | ID: mdl-32696976

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Vancomycin / Drug Delivery Systems / Methicillin-Resistant Staphylococcus aureus / Farnesol Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur Cell Mater Year: 2020 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Vancomycin / Drug Delivery Systems / Methicillin-Resistant Staphylococcus aureus / Farnesol Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur Cell Mater Year: 2020 Document type: Article Country of publication: